Drugs & medicalClass III

Teva Pharmaceuticals USA Inc recalls Montelukast Sodium Oral Granules USP, 4 mg, packaged in a carton containing 30 packets, Rx only, Distributed By: Teva…

Failed Impurities/Degradation Specifications: failed impurities for Sulphoxide and Impurity A.

Read the official notice →
Date
2023-04-12
Country
United States
Brand
Teva Pharmaceuticals
Product
Montelukast Sodium Oral Granules USP, 4 mg, packaged in a carton containing 30 packets, Rx only, Distributed By: Teva Pharmaceuticals USA,…
Classification
Class III
Units
USA Nationwide
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Teva Pharmaceuticals recalls

  1. 2023-12-06
  2. US
  3. 2023-07-19
  4. US
    Drugs & medicalClass II

    Teva Pharmaceuticals USA Inc recalls Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx only, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ…

    Failed Moisture Limits: Water (moisture) content above the approved product specifications.

    FDA · DrugTeva Pharmaceuticals USA IncProduct was distributed to 3 wholesalers/distributors who further distributed…Official notice →
  5. 2023-05-31
  6. US
  7. 2023-03-22
  8. US
    Drugs & medicalClass II

    Teva Pharmaceuticals USA Inc recalls Clear Eyes, Once Daily, Eye Allergy Itch Relief, olopatadine hydrochloride ophthalmic solution, USP, 0.2%, Antihistamine, 2.5 mL…

    Failed Impurities Specification: Out-of-specification (OOS) stability test result was obtained for unspecified impurity.

    FDA · DrugTeva Pharmaceuticals USA IncNationwide in the U.S.A.Official notice →
  9. 2023-03-15
  10. US
    Drugs & medicalClass II

    Teva Pharmaceuticals USA Inc recalls Metformin hydrochloride Extended-Release Tablets, 1000 mg, 60-count bottle, RX only, Manufactured by: Actavis Laboratories FL,…

    CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.

    FDA · DrugTeva Pharmaceuticals USA IncCAOfficial notice →
  11. 2022-09-21
  12. US
    Drugs & medicalClass II

    Teva Pharmaceuticals USA Inc recalls Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a…

    Labeling: Label Error on Declared Strength; A sealed 100-count bottle labeled with 15 mg actually contained 100 tablets of 20 mg strength of the drug product.

    FDA · DrugTeva Pharmaceuticals USA IncNationwide in the US.Official notice →
All 44 Teva Pharmaceuticals recalls →

Other drugs & medical recalls in the United States

  1. 2023-04-12
  2. US
    Drugs & medicalClass I

    Abbott Diabetes Care, Inc. recalls FreeStyle Libre Reader, REF: 71951-01, 71952-01, 71953-01 a component of the FreeStyle Libre 2 Flash Glucose Monitoring System

    Lithium-ion batteries in glucose monitoring system readers may swell, overheat, or pose fire hazard. Only use the charging cable/power adapter included with readers. Do not use reader if it is damaged, cracked,…

    FDA · DeviceAbbott Diabetes Care, Inc.U.S. Nationwide.Official notice →
  3. US
    Drugs & medicalClass III

    Accord Healthcare, Inc. recalls Dodex Injectable Cyanocobalamin Injection, USP 1,000 mcg/mL, 25 x1 ML Multiple dose vials, For Intramuscular or Subcutaneous Use Only, Rx…

    Sub-potent drug: assay test result below specifications at 9-month timepoint.

    FDA · DrugAccord Healthcare, Inc.Nationwide in the USA.Official notice →
  4. US
    Drugs & medicalClass II

    Preferred Pharmaceuticals, Inc. recalls Doxazosin Tablets, USP, 4 mg, 100-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7149-1

    cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

    FDA · DrugPreferred Pharmaceuticals, Inc.USA NationwideOfficial notice →
  5. US
    Drugs & medicalClass II

    Direct Rx recalls Alprazolam C-IV, 1 mg, packaged in a) 30 Tabs per bottle, NDC 72189-213-30; b) 60 Tabs per bottle, NDC 72189-213-60; Rx only, Packaged and…

    CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.

    FDA · DrugDirect RxNationwide in the USAOfficial notice →
  6. US
    Drugs & medicalClass II

    Preferred Pharmaceuticals, Inc. recalls Alprazolam Tab, USP 0.25mg, (CIV), 30-count bottle, Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by: Breckenridge…

    CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.

    FDA · DrugPreferred Pharmaceuticals, Inc.Nationwide in the USAOfficial notice →
  7. US
    Drugs & medicalClass II

    RemedyRepack Inc. recalls Simvastatin 10 mg tablets, packaged in a) 30-count bottles (NDC 70518-0064-01) and b) 90-count bottles (NDC 70518-0064-00), Rx only,…

    cGMP Deviations

    FDA · DrugRemedyRepack Inc.RemedyRepack distributed product to consignees nationwide within the United…Official notice →
See all drugs & medical recalls →